IDEXX Laboratories Inc had annual average EBITDA growth of 14.80% over the past ten years. IDEXX Laboratories, Inc. (NASDAQ:IDXX) Director Jonathan W. Ayers sold 11,440 shares of the stock in a transaction that occurred on Wednesday, November 4th.
Only 2.53% of the stock of IDEXX Laboratories is held by insiders. IDEXX Laboratories Aktie im Überblick: Realtimekurs, Chart, Fundamentaldaten, sowie aktuelle Nachrichten und Meinungen. 22, 2019 at 8:50 a.m. IDEXX Laboratories Inc. fertigt Diagnose- und IT-Lösungen in den Bereichen Tiergesundheit, Wasser- und Milchqualität. Want to see which stocks are moving?
There are currently no items in this Watchlist. Cookie Notice. Only 2.53% of the stock of IDEXX Laboratories is held by insiders. How is the medical sector tackling infertility?
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Die Gesellschaft ist an über 60 Standorten weltweit vertreten und liefert an Kunden in über 175 Ländern.
IDEXX Laboratories' stock is owned by a variety of institutional and retail investors. Get short term trading ideas from the MarketBeat Idea Engine. Zeitverzögerung der Kursdaten: Deutsche Börsen +15 Min.
© American Consumer News, LLC dba MarketBeat® 2010-2020.
The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. You may vote once every thirty days.
Tages-Trading-Chancen am Mittwoch den 11.11.2020, Auch mittelbar Betroffene sollen Corona-Hilfen erhalten, Trading-Chance des Monats! Sei Investments Co. now owns 37,343 shares of the company’s stock valued at $14,792,000 after purchasing an additional 14,339 shares during the period.
IDEXX Laboratories, Inc. Common Stock (IDXX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The P/E ratio of IDEXX Laboratories is 76.87, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 19.84. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day. IDEXX Laboratories had a return on equity of 198.91% and a net margin of 19.20%. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed.
The Company reports revenues of $722 million for the third quarter … Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.
NEUBEWERTUNG wird schnell kommen, Biontech-Jünger in Vorfreude: “Ich verkaufe kein Stück.
Diskussion: IDEXX Laboratories Inc. (IDXX), Bild: http://chart.finance.yahoo.com/z?s=IDXX&t=my&q=l&l=on&z=l&a=v&p=s&lang, Hier geht es zur neuesten Diskussion: IDEXX Laboratories, Derivate Cockpit - Finden Sie das beste Produkt zu Ihrer Kurserwartung, Russischer Staatsfonds: Corona-Impfstoff mit hoher Wirksamkeit, Intellia Therapeutics Receives Grant to Develop Curative CRISPR/Cas9 In Vivo Sickle Cell Disease Treatments, Hofseth Biocare ASA: COMPLETED EXTRAORDINARY GENERAL MEETING AND APPROVED SUBSEQUENT OFFERING, Moderna Announces Clinical Updates on Personalized Cancer Vaccine Program, AKTIE IM FOKUS: Bechtle begeistert Anleger mit Zahlen und höherem Gewinnziel, Börsen- & Finanzwidgets für Ihre Homepage. Company insiders that have sold IDEXX Laboratories company stock in the last year include Brian P Mckeon, Bruce L Claflin, Daniel M Junius, Giovani Twigge, James F Polewaczyk, Jonathan Jay Mazelsky, Jonathan W Ayers, M Anne Szostak, Michael Lane, Nimrata Hunt, and Rebecca M Henderson. agencies. View IDEXX Laboratories' earnings history. IDEXX Laboratories employs 9,200 workers across the globe. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. BidaskClub raised IDEXX Laboratories from a “buy” rating to a “strong-buy” rating in a research note on Wednesday, October 21st. Leading Veterinary Diagnostic Company Sees No COVID-19 Cases in Pets, Chartgalerie - Top / Flop Aktien Wochenrückblick Kalenderwoche 06/20.
IDEXX Laboratories' management team includes the following people: Start Your Risk-Free Trial Subscription Here, Advance Auto Parts (NYSE:AAP) Growth Accelerates, Shares Fall, 3 Stocks to Buy that Can Benefit from the Vaccine News, Workhorse Group (NASDAQ:WKHS) Is The Next EV Stock You Need To Buy, GrowGeneration: A Growth Stock for the Millennial Generation, Don't Count Beyond Meat (NASDAQ:BYND) Out Just Yet, Aurora Cannabis (NYSE:ACB) Pops On Outlook, Falls On Results. CEO Recent Trades: President & CEO Jonathan Jay Mazelsky sold 5,206 shares of IDXX stock on 11/05/2020 at the average price of $469.31. Diese Lithium-Aktie ist viel zu billig - NEUBEWERTUNG wird schnell kommen. IDXX stock opened at $478.10 on Monday. See what's happening in the market right now with MarketBeat's real-time news feed. High institutional ownership can be a signal of strong market trust in this company. According to analysts' consensus price target of $395.67, IDEXX Laboratories has a forecasted downside of 10.3% from its current price of $441.23. The latest IDEXX Laboratories Inc Common Stock USD0.10 share price.
View analysts' price targets for IDEXX Laboratories. Diese Lithium-Aktie ist viel zu billig! Since then, IDXX shares have increased by 91.5% and is now trading at $470.25.
IDEXX Laboratories does not currently pay a dividend.
Das Unternehmen unterstützt Tierarztpraxen dabei, ihre medizinische Versorgung weiterzuentwickeln und die Rentabilität der Einrichtungen zu steigern. Man trifft spektakuläre 28,1 g/t GOLD! If you're not sure which This buyback authorization authorizes the company to reacquire shares of its stock through open market purchases. Should Invesco Defensive Equity ETF (DEF) Be on Your Investing Radar? Third Quarter Results. Medizin, Futter, Haustierbedarf: 3 Aktien, die (nicht nur) Tierfreunde mögen würden!
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Director Jonathan W. Ayers sold 11,440 shares of the stock in a transaction that occurred on Wednesday, November 4th.
The company operates through Companion Animal Group; Water Quality Products; Livestock, Poultry and Dairy; and Other segments.
Based on aggregate information from My MarketBeat watchlists, some companies that other IDEXX Laboratories investors own include NVIDIA (NVDA), Netflix (NFLX), PayPal (PYPL), Mastercard (MA), Adobe (ADBE), Tesla (TSLA), Alibaba Group (BABA), Square (SQ), The Walt Disney (DIS) and Shopify (SHOP).
Do Not Sell My Information. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.
Historical and current end-of-day data provided by FACTSET. All rights reserved.